Latest news: Amgen's landmark OK for KRAS drug, inside Vertex 3.0, the big hunt for CAR-T in solid tumors, and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
We are heading off to a three-day weekend, as we observe Memorial Day on Monday. Luckily, we do have some long reads for you to sit back and take in, if you haven’t already. Did I mention that there’s also an awesome webinar you can catch up on?
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 109,900+ biopharma pros reading Endpoints daily — and it's free.